Metavention

About:

Metavention develops medical devices to help with interventional therapies for high blood pressure and other metabolic diseases.

Website: http://www.metavention.com

Top Investors: New Enterprise Associates, Versant Ventures, Sanderling Ventures, Horowitz Group, RK Mellon

Description:

Metavention develops new treatment that is intended to permanently disrupt the overactive nerves that cause high blood pressure and other metabolic diseases. They offer a renal denervation procedure that delivers radio frequency energy to targeted overactive sympathetic nerves using their IRF denervation system.

Total Funding Amount:

$65M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Eden Prairie, Minnesota, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)metavention.com

Founders:

Bobak Azamian, Scott Vafai

Number of Employees:

11-50

Last Funding Date:

2018-01-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai